Prof. Zhiwei Yu 于志伟
Chief Physician, Professor
Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Laparoscopic radical surgery for colorectal cancer, functional extended radical resection preserving pelvic autonomic nerves, and sphincter-preserving surgery for low and ultra-low rectal cancer. Advocates individualized and standardized treatment.
Dr. Yu is a Chief Physician, Professor, and Deputy Department Director. Dr. Yu completed postdoctoral training at Case Western Reserve University’s Ireland Cancer Center and studied at Japan’s National Cancer Center Institute. Research focuses on colorectal tumor biology and clinical translation, including tyrosine kinase receptors and biomarkers. Dr. Yu has published over 10 SCI papers and received the 2007 AACR-Gerald B. Grindey Memorial Scholar-in-training Award.
Professional roles
- Vice Chair, Youth Committee of Colorectal Cancer Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Abdominal Tumor Branch, Chinese Medical Education Association
- Vice Chair, Colorectal Cancer Professional Committee, Heilongjiang Anti-Cancer Association
- Chair, Youth Committee of Colorectal Cancer Professional Committee, Heilongjiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Yu Zhiwei). Papers usually list the name as Zhiwei Yu or Yu Z.
Selected publications
10 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biol Direct, 2026 (senior author): Cancer-associated fibroblasts-derived exosomal circ_0067557 promotes colorectal cancer epithelial-mesenchymal transition via BHLHE40-mediated transcriptional activation of OTUB2. PubMed 42115880
- BMC Cancer, 2024 (senior author): Exosomes derived from cancer-associated fibroblasts promote tumorigenesis, metastasis and chemoresistance of colorectal cancer by upregulating circ_0067557 to target Lin28. PubMed 38216964
- J Transl Med, 2023 (senior author): Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells. PubMed 37940972
- Neoplasma, 2021 (senior author): Determining the effects of Ephrin Type B Receptor 6 and Type A Receptor 3 on facilitating colorectal epithelial cell malignant transformation. PubMed 34196214
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion